This site is intended for healthcare professionals
Login | Register (NOW FREE)

Medical search

acute myeloid leukemia

FREE subscriptions for doctors and students... click here
You have 3 open access pages.

Acute myeloid leukaemia (AML) is a heterogeneous clonal disorder characterised by the arrest of differentiation of the progenitor cells (“blasts”) coupled with an accumulation of immature progenitors in the bone marrow, resulting in hematopoietic failure (1).

  • AML is generally a disease of older adults - median age at diagnosis between 65 and 70 year of age
  • after age 5-10, every year of age worsens the prognosis for patients with AML
  • AML in older individuals is a more recalcitrant disease
    • the disease tends to be less proliferative with average bone marrow blast counts of 20% in those older than 60 and 40% in those younger than 60. When compared with those younger than 56, those older than 56 are less likely to have favorable cytogenetics (16% vs. 5%) and more likely to have unfavorable cytogenetics (33% vs. 50%)



The information provided herein should not be used for diagnosis or treatment of any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright 2016 Oxbridge Solutions LtdĀ®. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions LtdĀ® receives funding from advertising but maintains editorial independence. GPnotebook stores small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use GPnotebook.